Dec 12 (Reuters) - Active Biotech AB ACTI.ST says:
* Active biotech's rights issue completed
* Active biotech ab says approximately 96 percent of shares
offered, were subscribed for with subscription rights
* Active biotech ab says through rights issue, active
biotech receives proceeds amounting to approximately sek 55
million, before issue expenses
* Trading in the new shares on Nasdaq Stockholm is expected
to commence on or about 27 December
Source text for Eikon: ID:nGNE34BQp6
Further company coverage: ACTI.ST
(Reporting By Anna Ringstrom)
((Anna.Ringstrom@thomsonreuters.com;))